DUSPATALIN 200mg prolonged release capsules medication leaflet

A03AA04 mebeverine • Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, esters with tertiary amino group

Mebeverine is a medication used to treat symptoms associated with functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS). It is an antispasmodic that acts on the smooth muscles of the intestine, reducing spasms and alleviating symptoms such as abdominal pain, bloating, and intestinal discomfort.

Mebeverine does not affect normal intestinal motility, making it a safe option for long-term use. It is available in tablet or extended-release capsule form and is usually taken before meals.

Side effects are rare but may include nausea, dizziness, allergic reactions (such as skin rashes), or, in very rare cases, difficulty breathing. It is important to take the medication as prescribed by a doctor and avoid self-medication.

DUSPATALIN 200mg prolonged release capsules BGP PRODUCTS, mebeverine

General data about DUSPATALIN 200mg

Substance: mebeverine

Date of last drug list: 10-04-2026

Commercial code: W62373002

Concentration: 200mg

Pharmaceutical form: prolonged release capsules

Quantity: 30

Product type: original

Price: 30.52 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: MYLAN LABORATORIES S.A.S. - OLANDA

Holder: MYLAN HEALTHCARE B.V. - OLANDA

Number: 902/2008/01

Shelf life: 3 years

Pharmaceutical forms available for mebeverine

Concentrations available for mebeverine

100mg, 200mg

Other substances similar to mebeverine

Compensation lists for DUSPATALIN 200mg BGP PRODUCTS

D - Sublist D with 20% discount from the reference price

Price

Copayment

Patient

30.52 RON

6.10 RON

24.42 RON